CACNB3 Rabbit Polyclonal Antibody – TA330294 | Origene

Total Page：16

File Type：pdf, Size：1020Kb

CACNB3 Rabbit Polyclonal Antibody – TA330294 | Origene

OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA330294 CACNB3 Rabbit Polyclonal Antibody Product data: Product Type: Primary Antibodies Applications: WB Recommended Dilution: WB Reactivity: Human Host: Rabbit Isotype: IgG Clonality: Polyclonal Immunogen: The immunogen for Anti-CACNB3 antibody is: synthetic peptide directed towards the C- terminal region of Human CACNB3. Synthetic peptide located within the following region: QDLYQPHRQHTSGLPSANGHDPQDRLLAQDSEHNHSDRNWQRNRPWPKDS Formulation: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. Note that this product is shipped as lyophilized powder to China customers. Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 51 kDa Gene Name: calcium voltage-gated channel auxiliary subunit beta 3 Database Link: NP_001193846 Entrez Gene 784 Human P54284 Background: The beta subunit of voltage-dependent calcium channels contributes to the function of the calcium channel by increasing peak calcium current, shifting the voltage dependencies of activation and inactivation, modulating G protein inhibition and controlling the alpha-1 subunit membrane targeting. Synonyms: CAB3; CACNLB3 Note: Immunogen sequence homology: Human: 100%; Dog: 93%; Pig: 93%; Rat: 93%; Horse: 93%; Rabbit: 93%; Guinea pig: 93%; Mouse: 86%; Bovine: 86% This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 CACNB3 Rabbit Polyclonal Antibody – TA330294 Protein Families: Druggable Genome, Ion Channels: Other Protein Pathways: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway Product images: Host: Rabbit; Target Name: CACNB3; Sample Tissue: Hela Whole Cell lysates; Antibody Dilution: 1.0ug/ml This product is to be used for laboratory only. Not for diagnostic or therapeutic use. ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 2 / 2.

Copy Link

Recommended publications

The Mineralocorticoid Receptor Leads to Increased Expression of EGFR
www.nature.com/scientificreports OPEN The mineralocorticoid receptor leads to increased expression of EGFR and T‑type calcium channels that support HL‑1 cell hypertrophy Katharina Stroedecke1,2, Sandra Meinel1,2, Fritz Markwardt1, Udo Kloeckner1, Nicole Straetz1, Katja Quarch1, Barbara Schreier1, Michael Kopf1, Michael Gekle1 & Claudia Grossmann1* The EGF receptor (EGFR) has been extensively studied in tumor biology and recently a role in cardiovascular pathophysiology was suggested. The mineralocorticoid receptor (MR) is an important efector of the renin–angiotensin–aldosterone‑system and elicits pathophysiological efects in the cardiovascular system; however, the underlying molecular mechanisms are unclear. Our aim was to investigate the importance of EGFR for MR‑mediated cardiovascular pathophysiology because MR is known to induce EGFR expression. We identifed a SNP within the EGFR promoter that modulates MR‑induced EGFR expression. In RNA‑sequencing and qPCR experiments in heart tissue of EGFR KO and WT mice, changes in EGFR abundance led to diferential expression of cardiac ion channels, especially of the T‑type calcium channel CACNA1H. Accordingly, CACNA1H expression was increased in WT mice after in vivo MR activation by aldosterone but not in respective EGFR KO mice. Aldosterone‑ and EGF‑responsiveness of CACNA1H expression was confrmed in HL‑1 cells by Western blot and by measuring peak current density of T‑type calcium channels. Aldosterone‑induced CACNA1H protein expression could be abrogated by the EGFR inhibitor AG1478. Furthermore, inhibition of T‑type calcium channels with mibefradil or ML218 reduced diameter, volume and BNP levels in HL‑1 cells. In conclusion the MR regulates EGFR and CACNA1H expression, which has an efect on HL‑1 cell diameter, and the extent of this regulation seems to depend on the SNP‑216 (G/T) genotype.
[Show full text]
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
[Show full text]
Spatial Distribution of Leading Pacemaker Sites in the Normal, Intact Rat Sinoa
Supplementary Material Supplementary Figure 1: Spatial distribution of leading pacemaker sites in the normal, intact rat sinoatrial 5 nodes (SAN) plotted along a normalized y-axis between the superior vena cava (SVC) and inferior vena 6 cava (IVC) and a scaled x-axis in millimeters (n = 8). Colors correspond to treatment condition (black: 7 baseline, blue: 100 µM Acetylcholine (ACh), red: 500 nM Isoproterenol (ISO)). 1 Supplementary Figure 2: Spatial distribution of leading pacemaker sites before and after surgical 3 separation of the rat SAN (n = 5). Top: Intact SAN preparations with leading pacemaker sites plotted during 4 baseline conditions. Bottom: Surgically cut SAN preparations with leading pacemaker sites plotted during 5 baseline conditions (black) and exposure to pharmacological stimulation (blue: 100 µM ACh, red: 500 nM 6 ISO). 2 a &DUGLDFIoQChDQQHOV .FQM FOXVWHU &DFQDG &DFQDK *MD &DFQJ .FQLS .FQG .FQK .FQM &DFQDF &DFQE .FQM í $WSD .FQD .FQM í .FQN &DVT 5\U .FQM &DFQJ &DFQDG ,WSU 6FQD &DFQDG .FQQ &DFQDJ &DFQDG .FQD .FQT 6FQD 3OQ 6FQD +FQ *MD ,WSU 6FQE +FQ *MG .FQN .FQQ .FQN .FQD .FQE .FQQ +FQ &DFQDD &DFQE &DOP .FQM .FQD .FQN .FQG .FQN &DOP 6FQD .FQD 6FQE 6FQD 6FQD ,WSU +FQ 6FQD 5\U 6FQD 6FQE 6FQD .FQQ .FQH 6FQD &DFQE 6FQE .FQM FOXVWHU V6$1 L6$1 5$ /$ 3 b &DUGLDFReFHSWRUV $GUDF FOXVWHU $GUDD &DY &KUQE &KUP &KJD 0\O 3GHG &KUQD $GUE $GUDG &KUQE 5JV í 9LS $GUDE 7SP í 5JV 7QQF 3GHE 0\K $GUE *QDL $QN $GUDD $QN $QN &KUP $GUDE $NDS $WSE 5DPS &KUP 0\O &KUQD 6UF &KUQH $GUE &KUQD FOXVWHU V6$1 L6$1 5$ /$ 4 c 1HXURQDOPURWHLQV
[Show full text]
Patterns of Gene Expression in the Ductus Arteriosus Are Related to Environmental and Genetic Risk Factors for Persistent Ductus Patency
0031-3998/10/6804-0292 Vol. 68, No. 4, 2010 PEDIATRIC RESEARCH Printed in U.S.A. Copyright © 2010 International Pediatric Research Foundation, Inc. Patterns of Gene Expression in the Ductus Arteriosus Are Related to Environmental and Genetic Risk Factors for Persistent Ductus Patency NAHID WALEH, RYAN HODNICK, NAMI JHAVERI, SUZANNE McCONAGHY, JOHN DAGLE, STEVEN SEIDNER, DONALD McCURNIN, JEFFREY C. MURRAY, ROBIN OHLS, AND RONALD I. CLYMAN Pharmaceutical Discovery Division [N.W.], SRI International, Menlo Park, California 94025; Department of Pediatrics [R.H., S.M., R.O.], University of New Mexico, Albuquerque, New Mexico 87131; Department of Pediatrics [N.J., R.I.C.], Cardiovascular Research Institute, University of California San Francisco, California 94143; Department of Pediatrics [J.D., J.C.M.], University of Iowa, Iowa City, Iowa 52242; Department of Pediatrics [S.S., D.M.], University of Texas, Health Science Center, San Antonio, Texas 78229; Southwest Foundation for Biomedical Research [D.M.], San Antonio, Texas 78227 ABSTRACT: Three independent risk factors (immature gestation, term infants will close their PDA when prostaglandin produc- absence of antenatal glucocorticoid exposure, and presence of the tion is inhibited by indomethacin or ibuprofen. However, rs2817399(A) allele of the gene TFAP2B) are associated with patent approximately 30% of PDAs are the result of factors that are ductus arteriosus (PDAs) that fail to close during prostaglandin independent of prostaglandin signaling. In these infants, the inhibition. We hypothesized that these three factors may affect a PDAs fail to close when prostaglandin production is inhibited common set of genes that increase the risk of persistent PDA after (3,4).
[Show full text]
Pflugers Final
CORE Metadata, citation and similar papers at core.ac.uk Provided by Serveur académique lausannois A comprehensive analysis of gene expression profiles in distal parts of the mouse renal tubule. Sylvain Pradervand2, Annie Mercier Zuber1, Gabriel Centeno1, Olivier Bonny1,3,4 and Dmitri Firsov1,4 1 - Department of Pharmacology and Toxicology, University of Lausanne, 1005 Lausanne, Switzerland 2 - DNA Array Facility, University of Lausanne, 1015 Lausanne, Switzerland 3 - Service of Nephrology, Lausanne University Hospital, 1005 Lausanne, Switzerland 4 – these two authors have equally contributed to the study to whom correspondence should be addressed: Dmitri FIRSOV Department of Pharmacology and Toxicology, University of Lausanne, 27 rue du Bugnon, 1005 Lausanne, Switzerland Phone: ++ 41-216925406 Fax: ++ 41-216925355 e-mail: [email protected] and Olivier BONNY Department of Pharmacology and Toxicology, University of Lausanne, 27 rue du Bugnon, 1005 Lausanne, Switzerland Phone: ++ 41-216925417 Fax: ++ 41-216925355 e-mail: [email protected] 1 Abstract The distal parts of the renal tubule play a critical role in maintaining homeostasis of extracellular fluids. In this review, we present an in-depth analysis of microarray-based gene expression profiles available for microdissected mouse distal nephron segments, i.e., the distal convoluted tubule (DCT) and the connecting tubule (CNT), and for the cortical portion of the collecting duct (CCD) (Zuber et al., 2009). Classification of expressed transcripts in 14 major functional gene categories demonstrated that all principal proteins involved in maintaining of salt and water balance are represented by highly abundant transcripts. However, a significant number of transcripts belonging, for instance, to categories of G protein-coupled receptors (GPCR) or serine-threonine kinases exhibit high expression levels but remain unassigned to a specific renal function.
[Show full text]
Downregulation of Carnitine Acyl-Carnitine Translocase by Mirnas
Page 1 of 288 Diabetes 1 Downregulation of Carnitine acyl-carnitine translocase by miRNAs 132 and 212 amplifies glucose-stimulated insulin secretion Mufaddal S. Soni1, Mary E. Rabaglia1, Sushant Bhatnagar1, Jin Shang2, Olga Ilkayeva3, Randall Mynatt4, Yun-Ping Zhou2, Eric E. Schadt6, Nancy A.Thornberry2, Deborah M. Muoio5, Mark P. Keller1 and Alan D. Attie1 From the 1Department of Biochemistry, University of Wisconsin, Madison, Wisconsin; 2Department of Metabolic Disorders-Diabetes, Merck Research Laboratories, Rahway, New Jersey; 3Sarah W. Stedman Nutrition and Metabolism Center, Duke Institute of Molecular Physiology, 5Departments of Medicine and Pharmacology and Cancer Biology, Durham, North Carolina. 4Pennington Biomedical Research Center, Louisiana State University system, Baton Rouge, Louisiana; 6Institute for Genomics and Multiscale Biology, Mount Sinai School of Medicine, New York, New York. Corresponding author Alan D. Attie, 543A Biochemistry Addition, 433 Babcock Drive, Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, (608) 262-1372 (Ph), (608) 263-9608 (fax), [email protected]. Running Title: Fatty acyl-carnitines enhance insulin secretion Abstract word count: 163 Main text Word count: 3960 Number of tables: 0 Number of figures: 5 Diabetes Publish Ahead of Print, published online June 26, 2014 Diabetes Page 2 of 288 2 ABSTRACT We previously demonstrated that micro-RNAs 132 and 212 are differentially upregulated in response to obesity in two mouse strains that differ in their susceptibility to obesity-induced diabetes. Here we show the overexpression of micro-RNAs 132 and 212 enhances insulin secretion (IS) in response to glucose and other secretagogues including non-fuel stimuli. We determined that carnitine acyl-carnitine translocase (CACT, Slc25a20) is a direct target of these miRNAs.
[Show full text]
RT² Profiler PCR Array (96-Well Format and 384-Well [4 X 96] Format)
RT² Profiler PCR Array (96-Well Format and 384-Well [4 x 96] Format) Mouse Neuronal Ion Channels Cat. no. 330231 PAMM-036ZA For pathway expression analysis Format For use with the following real-time cyclers RT² Profiler PCR Array, Applied Biosystems® models 5700, 7000, 7300, 7500, Format A 7700, 7900HT, ViiA™ 7 (96-well block); Bio-Rad® models iCycler®, iQ™5, MyiQ™, MyiQ2; Bio-Rad/MJ Research Chromo4™; Eppendorf® Mastercycler® ep realplex models 2, 2s, 4, 4s; Stratagene® models Mx3005P®, Mx3000P®; Takara TP-800 RT² Profiler PCR Array, Applied Biosystems models 7500 (Fast block), 7900HT (Fast Format C block), StepOnePlus™, ViiA 7 (Fast block) RT² Profiler PCR Array, Bio-Rad CFX96™; Bio-Rad/MJ Research models DNA Format D Engine Opticon®, DNA Engine Opticon 2; Stratagene Mx4000® RT² Profiler PCR Array, Applied Biosystems models 7900HT (384-well block), ViiA 7 Format E (384-well block); Bio-Rad CFX384™ RT² Profiler PCR Array, Roche® LightCycler® 480 (96-well block) Format F RT² Profiler PCR Array, Roche LightCycler 480 (384-well block) Format G RT² Profiler PCR Array, Fluidigm® BioMark™ Format H Sample & Assay Technologies Description The Mouse Neuronal Ion Channels RT² Profiler PCR Array was developed to profile expression of a panel of 84 genes encoding neuroscience-related ion channels and transporters. The genes represented on the array are listed below, grouped according to their functional and structural features. Included are calcium channels, potassium channels, sodium channels, chloride channels, and transporters. Using real-time PCR, you can easily and reliably analyze expression of a focused panel of genes related to the neuronal ion channels and transporters with this array.
[Show full text]
Role of Two Genes, Cacna1d and Cadm1, with Common Or Rare Mutations in Aldosterone Producing Adenomas of the Adrenal
ROLE OF TWO GENES, CACNA1D AND CADM1, WITH COMMON OR RARE MUTATIONS IN ALDOSTERONE PRODUCING ADENOMAS OF THE ADRENAL. SUMEDHA GARG GONVILLE AND CAIUS COLLEGE UNIVERSITY OF CAMBRIDGE DECEMBER 2018 This dissertation is submitted for the degree of Doctor of Philosophy ROLE OF TWO GENES, CACNA1D AND CADM1, WITH COMMON OR RARE MUTATIONS IN ALDOSTERONE PRODUCING ADENOMAS OF THE ADRENAL Submitted By – Ms Sumedha Garg Primary aldosteronism (PA) accounts for 5-10% of all hypertension. One of the major causes of PA is sporadic formation of aldosterone-producing adenomas (APAs). These benign tumours develop in the cortical region of adrenal glands and autonomously secrete excessive amounts of aldosterone. This hormone increases sodium retention and water reabsorption by the kidneys, leading to high blood pressure. Landmark discoveries of somatic mutations in APAs led to better understanding of molecular mechanisms causing autonomous aldosterone secretion. The first mutations were found in KCNJ5, followed by ATP1A1, ATP2B3 and CACNA1D, all encoding cation-channels or transporters. Several in vitro studies showed disruption of cellular ion-balance leading to the phenotype of hyper-aldosterone secretion from APAs. Following our lab’s discovery of initial four somatic mutations by whole exome sequencing, over 30 single-base change mutations have been reported in the CACNA1D gene, which 2+ encodes the 1 subunit of an L-type Ca channel (LTCC), CaV1.3. Initial and several subsequent mutations cause electrophysiological gain-of-function with increased activation and/or 2+ slowed inactivation of CaV1.3. Prior to the discovery of these mutations, L-type Ca channels were not considered important in regulation of aldosterone production.
[Show full text]
Calcium Channel Genes Associated with Bipolar Disorder Modulate Lithium’S Amplification of Circadian Rhythms
Accepted Manuscript Calcium channel genes associated with bipolar disorder modulate lithium’s amplification of circadian rhythms Michael J. McCarthy, Melissa LeRoux, Heather Wei, Stephen Beesley, John R. Kelsoe, David K. Welsh PII: S0028-3908(15)30141-6 DOI: 10.1016/j.neuropharm.2015.10.017 Reference: NP 6042 To appear in: Neuropharmacology Received Date: 26 June 2015 Revised Date: 8 October 2015 Accepted Date: 10 October 2015 Please cite this article as: McCarthy, M.J., LeRoux, M., Wei, H., Beesley, S., Kelsoe, J.R., Welsh, D.K., Calcium channel genes associated with bipolar disorder modulate lithium’s amplification of circadian rhythms, Neuropharmacology (2015), doi: 10.1016/j.neuropharm.2015.10.017. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. ACCEPTED MANUSCRIPT CALCIUM CHANNEL GENES ASSOCIATED WITH BIPOLAR DISORDER MODULATE LITHIUM’S AMPLIFICATION OF CIRCADIAN RHYTHMS Michael J. McCarthy MD, PhD 1,2 , Melissa LeRoux 2, Heather Wei MS 1, Stephen Beesley PhD 2, John R. Kelsoe MD 1,2 , David K. Welsh MD, PhD 1,2 1) Research and Psychiatry Service, Veterans Affairs San Diego 2) Department of Psychiatry and Center for Circadian Biology, University of California San Diego Corresponding Author: Michael J.
[Show full text]
Gene List HTG Edgeseq Oncology Biomarker Panel
Gene List HTG EdgeSeq Oncology Biomarker Panel For Research Use Only. Not for use in diagnostic procedures. A2M ADRA2B APH1B BAG1 BRCA2 CARM1 CCNH CDC25A CHI3L1 COX7B CXCL16 DESI1 ABCA2 ADRA2C APOC2 BAG2 BRIP1 CASP1 CCNO CDC25B CHI3L2 CP CXCL2 DFFA ABCA3 AFF1 APOC4 BAG3 BTC CASP10 CCNT1 CDC25C CHMP4B CPT1A CXCL3 DHCR24 ABCA4 AGER APOL3 BAG4 BTG1 CASP12 CCR1 CDC34 CHPT1 CPT1B CXCL5 DHH ABCA5 AGFG1 APP BAG5 BTG2 CASP14 CCR10 CDC42 CHRNA1 CPT1C CXCL6 DHX58 ABCA9 AGGF1 APPBP2 BAI1 BTG3 CASP2 CCR2 CDC42BPA CHRNB1 CPT2 CXCL8 DIABLO ABCB11 AGT AQP1 BAIAP3 BTK CASP3 CCR3 CDC6 CHSY1 CRADD CXCL9 DIAPH3 ABCB4 AHNAK AQP2 BAK1 BTRC CASP4 CCR4 CDC7 CHUK CREB1 CXCR1 DICER1 ABCB5 AHNAK2 AQP4 BAMBI BUB1 CASP5 CCR5 CDCA7 CIC CREB3L1 CXCR2 DISP1 ABCB6 AHR AQP7 BAP1 BUB1B CASP6 CCR6 CDH1 CIDEA CREB3L3 CXCR3 DISP2 ABCC1 AHRR AQP9 BATF C17orf53 CASP7 CCR7 CDH13 CIDEB CREB3L4 CXCR4 DKC1 ABCC10 AICDA AR BAX C19orf40 CASP8 CCR8 CDH15 CIRBP CREB5 CXCR5 DKK1 ABCC11 AIFM1 ARAF BBC3 C1orf106 CASP8AP2 CCR9 CDH2 CITED2 CREBBP CXCR6 DKK2 ABCC12 AIMP2 AREG BBS4 C1orf159 CASP9 CCRL2 CDH3 CKB CRK CXXC4 DKK3 ABCC2 AK1 ARHGAP44 BCAR1 C1orf86 CAV1 CCS CDH5 CKLF CRLF2 CXXC5 DKK4 ABCC3 AK2 ARHGEF16 BCAT1 C1QA CAV2 CCT2 CDK1 CKMT1A CRLS1 CYBA DLC1 ABCC4 AK3 ARID1A BCCIP C1S CBL CCT3 CDK16 CKMT2 CRP CYBB DLGAP5 ABCC5 AKAP1 ARID1B BCL10 C3 CBLC CCT4 CDK2 CKS1B CRTAC1 CYCS DLK1 ABCC6 AKR1B1 ARID2 BCL2 C3AR1 CBX3 CCT5 CDK4 CKS2 CRTC2 CYLD DLL1 ABCD1 AKR1C3 ARMC1 BCL2A1 C5 CBX5 CCT6A CDK5 CLCA2 CRY1 CYP19A1 DLL3 ABCD3 AKT1 ARNT BCL2L1 C5AR1 CCBL2 CCT6B CDK5R1 CLCF1 CRYAA CYP1A1 DLL4
[Show full text]
CACNB3 Antibody
Efficient Professional Protein and Antibody Platforms CACNB3 Antibody Basic information: Catalog No.: UPA60327 Source: Rabbit Size: 50ul/100ul Clonality: Polyclonal Concentration: 1mg/ml Isotype: Rabbit IgG Purification: Peptide affinity purified. Useful Information: WB:1:500 Applications: IHC:1:50-1:200 FC:1:50-1:100 Reactivity: Human, Mouse, Rat Specificity: This antibody recognizes CACNB3 protein. Immunogen: Synthetic peptide within C-terminal human CACNB3. Regulatory subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents. Increases CACNA1B peak calcium current and shifts Description: the voltage dependencies of channel activation and inactivation. Increases CACNA1C peak calcium current and shifts the voltage dependencies of channel activation and inactivation. Uniprot: P54284(Human) P54285(Mouse) P54287(Rat) BiowMW: 55 kDa (Predicted band size) Buffer: 1*TBS (pH7.4), 0.5%BSA, 50%Glycerol. Preservative: 0.05% Sodium Azide. Storage: Store at 4°C short term and -20°C long term. Avoid freeze-thaw cycles. Note: For research use only, not for use in diagnostic procedure. Data: Western blot analysis of CACNB3 on different ly- sates using anti-CACNB3 antibody at 1/500 dilu- tion. Positive control： Lane1: Rat brain tissue Lane2: SKOV-3 Gene Universal Technology Co. Ltd www.universalbiol.com Tel: 0550-3121009 E-mail: [email protected] Efficient Professional Protein and Antibody Platforms Immunohistochemical analysis of paraf- fin-embedded rat brain tissue using anti-CACNB3 antibody. Counter stained with hematoxylin. Immunohistochemical analysis of paraf- fin-embedded human uterus tissue using an- ti-CACNB3 antibody. Counter stained with hema- toxylin. Immunohistochemical analysis of paraf- fin-embedded mouse ovary tissue using an- ti-CACNB3 antibody.
[Show full text]
Constitutive Activity of the Ghrelin Receptor Reduces Surface 2+ Expression of Voltage-Gated Ca Channels in a Cavβ-Dependent Manner Emilio R
© 2017. Published by The Company of Biologists Ltd | Journal of Cell Science (2017) 130, 3907-3917 doi:10.1242/jcs.207886 RESEARCH ARTICLE Constitutive activity of the Ghrelin receptor reduces surface 2+ expression of voltage-gated Ca channels in a CaVβ-dependent manner Emilio R. Mustafá1, Eduardo J. López Soto2, Valentina Martıneź Damonte1, Silvia S. Rodrıgueź 1, Diane Lipscombe2 and Jesica Raingo1,* ABSTRACT channels in different cells (Dolphin, 2012). CaV channels associate 2+ with various proteins and these auxiliary subunits influence their Voltage-gated Ca (CaV) channels couple membrane depolarization to Ca2+ influx, triggering a range of Ca2+-dependent cellular processes. trafficking to the plasma membrane (Dolphin, 2016; Felix et al., β α δ Ca channels are, therefore, crucial in shaping neuronal activity and 2013; Simms and Zamponi, 2012). CaV and CaV 2 are important V α function, depending on their individual temporal and spatial properties. auxiliary subunits that promote displacement of CaV 1 subunits Furthermore, many neurotransmitters and drugs that act through from the endoplasmic reticulum (ER), and influence forward G protein coupled receptors (GPCRs), modulate neuronal activity by trafficking as well as stability at the plasma membrane (Felix et al., 2013; Dolphin, 2012). The influence of auxiliary subunits on CaV3 altering the expression, trafficking, or function of CaV channels. GPCR- channels is less clear (Bichet et al., 2000; Fang and Colecraft, 2011; dependent mechanisms that downregulate CaV channel expression levels are observed in many neurons but are, by comparison, less De Waard et al., 1994). Post-translational modifications, including studied. Here we show that the growth hormone secretagogue receptor asparagine-linked glycosylation, are known to promote cell surface type 1a (GHSR), a GPCR, can inhibit the forwarding trafficking of expression of CaV3.2 (Weiss et al., 2013; Orestes et al., 2013) and indicate differences between the basic mechanisms controlling the several CaV subtypes, even in the absence of agonist.
[Show full text]